Tirzepatide Results Timeline
What the standard Tirzepatide research protocol looks like phase by phase, over a typical 16–72 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce weekly
CYCLE LENGTH16–72 weeks
DOSE RANGE2.5–15 mg weekly
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–4
Target dose: 2.5 mg
Escalation
Weeks 5–8
Target dose: 5.0 mg
Escalation
Weeks 9–12
Target dose: 7.5 mg
Maintenance
Weeks 13+
Target dose: 10–15 mg
Reported in Research
- ✓Dose escalation occurs every 4 weeks.
- ✓Titration pace: increase every 4 weeks only if tolerated.
- ✓Protocol length varies; weight management research typically extends 20+ weeks.
This timeline reflects the structure of the standard Tirzepatide research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.